Search Results

There are 3471 results for: content related to: Personalized medicine comes to cystic fibrosis

  1. You have free access to this content
    Poster Session Abstracts

    Pediatric Pulmonology

    Volume 50, Issue S41, October 2015, Pages: S193–S453,

    Version of Record online : 4 SEP 2015, DOI: 10.1002/ppul.23297

    Corrected by:

    Errata: Errata

    Vol. 50, Issue 12, 1175, Version of Record online: 9 NOV 2015

  2. You have free access to this content
    Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis

    Intervention Review

    The Cochrane Library

    Sanjay Patel, Ian P Sinha, Kerry Dwan, Carlos Echevarria, Michael Schechter and Kevin W Southern

    Published Online : 26 MAR 2015, DOI: 10.1002/14651858.CD009841.pub2

  3. You have free access to this content
    Poster Session Abstracts

    Pediatric Pulmonology

    Volume 51, Issue S45, October 2016, Pages: S194–S485,

    Version of Record online : 21 SEP 2016, DOI: 10.1002/ppul.23576

  4. You have free access to this content
    Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors

    Pediatric Pulmonology

    Volume 50, Issue S40, October 2015, Pages: S3–S13, George M. Solomon, Susan G. Marshall, Bonnie W. Ramsey and Steven M. Rowe

    Version of Record online : 19 JUN 2015, DOI: 10.1002/ppul.23240

  5. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype

    Clinical Pharmacology & Therapeutics

    Volume 95, Issue 6, June 2014, Pages: 592–597, J P Clancy, S G Johnson, S W Yee, E M McDonagh, K E Caudle, T E Klein, M Cannavo and K M Giacomini

    Version of Record online : 5 MAR 2014, DOI: 10.1038/clpt.2014.54

  6. Efficacy response in CF patients treated with ivacaftor: Post-hoc analysis

    Pediatric Pulmonology

    Volume 50, Issue 5, May 2015, Pages: 447–455, Michael W. Konstan, Barry J. Plant, J. Stuart Elborn, Sally Rodriguez, Anne Munck, Richard Ahrens and Charles Johnson

    Version of Record online : 9 MAR 2015, DOI: 10.1002/ppul.23173

  7. You have free access to this content
    Can Cystic Fibrosis Patients Finally Catch a Breath With Lumacaftor/Ivacaftor?

    Clinical Pharmacology & Therapeutics

    Volume 101, Issue 1, January 2017, Pages: 130–141, EK Schneider, F Reyes-Ortega, J Li and T Velkov

    Version of Record online : 23 NOV 2016, DOI: 10.1002/cpt.548

  8. Drug–drug plasma protein binding interactions of ivacaftor

    Journal of Molecular Recognition

    Volume 28, Issue 6, June 2015, Pages: 339–348, Elena K. Schneider, Johnny X. Huang, Vincenzo Carbone, Mark Baker, Mohammad A. K. Azad, Matthew A. Cooper, Jian Li and Tony Velkov

    Version of Record online : 24 FEB 2015, DOI: 10.1002/jmr.2447

  9. You have free access to this content
    Symposium Session Summaries

    Pediatric Pulmonology

    Volume 49, Issue S38, September 2014, Pages: S116–S215,

    Version of Record online : 4 SEP 2014, DOI: 10.1002/ppul.23107

  10. Ivacaftor improves appearance of sinus disease on computerised tomography in cystic fibrosis patients with G551D mutation

    Clinical Otolaryngology

    Volume 40, Issue 1, February 2015, Pages: 16–21, S.I. Sheikh, F.R. Long, K.S. McCoy, T. Johnson, N.A. Ryan-Wenger and D. Hayes Jr

    Version of Record online : 22 JAN 2015, DOI: 10.1111/coa.12310

  11. The pharmacokinetic interaction between ivacaftor and ritonavir in healthy volunteers

    British Journal of Clinical Pharmacology

    Anne Marie Liddy, Gavin McLaughlin, Susanne Schmitz, Deirdre M. D'Arcy and Michael G. Barry

    Version of Record online : 27 JUN 2017, DOI: 10.1111/bcp.13324

  12. In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies

    Pediatric Pulmonology

    Volume 52, Issue 4, April 2017, Pages: 472–479, Meghan E. McGarry, Beate Illek, Ngoc P. Ly, Lorna Zlock, Sabrina Olshansky, Courtney Moreno, Walter E. Finkbeiner and Dennis W. Nielson

    Version of Record online : 9 JAN 2017, DOI: 10.1002/ppul.23659

  13. CFTR-dependent chloride efflux in cystic fibrosis mononuclear cells is increased by ivacaftor therapy

    Pediatric Pulmonology

    Volume 52, Issue 7, July 2017, Pages: 900–908, Lorenzo Guerra, Susanna D'Oria, Maria Favia, Stefano Castellani, Teresa Santostasi, Angela M. Polizzi, Maria A. Mariggiò, Crescenzio Gallo, Valeria Casavola, Pasqualina Montemurro, Giuseppina Leonetti, Antonio Manca and Massimo Conese

    Version of Record online : 26 APR 2017, DOI: 10.1002/ppul.23712

  14. You have free access to this content
    Poster Session Abstracts

    Pediatric Pulmonology

    Volume 47, Issue S35, September 2012, Pages: 223–446,

    Version of Record online : 13 SEP 2012, DOI: 10.1002/ppul.22682

  15. You have free access to this content
    Symposium Summaries

    Pediatric Pulmonology

    Volume 50, Issue S41, October 2015, Pages: S108–S192,

    Version of Record online : 4 SEP 2015, DOI: 10.1002/ppul.23296

  16. You have free access to this content
    CFTR potentiators partially restore channel function to A561E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTR

    British Journal of Pharmacology

    Volume 171, Issue 19, October 2014, Pages: 4490–4503, Yiting Wang, Jia Liu, Avgi Loizidou, Luc A Bugeja, Ross Warner, Bethan R Hawley, Zhiwei Cai, Ashley M Toye, David N Sheppard and Hongyu Li

    Version of Record online : 5 SEP 2014, DOI: 10.1111/bph.12791

  17. You have full text access to this OnlineOpen article
    Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation

    Respirology Case Reports

    Volume 1, Issue 2, December 2013, Pages: 52–54, Michelle E. Wood, Daniel J. Smith, David W. Reid, Philip J. Masel, Megan W. France and Scott C. Bell

    Version of Record online : 10 OCT 2013, DOI: 10.1002/rcr2.27

  18. You have free access to this content
    Posters

    Pediatric Pulmonology

    Volume 50, Issue S41, October 2015, Pages: S77–S107,

    Version of Record online : 4 SEP 2015, DOI: 10.1002/ppul.23295

  19. Pseudomonas eradication and clinical effectivness of Ivacaftor in four Hispanic patients with S549N

    Pediatric Pulmonology

    Volume 52, Issue 7, July 2017, Pages: E37–E39, Abigail Strang, Anthony J. Fischer and Aaron Chidekel

    Version of Record online : 3 APR 2017, DOI: 10.1002/ppul.23665

  20. Functional defect of variants in the adenosine triphosphate–binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX-770)

    Hepatology

    Volume 65, Issue 2, February 2017, Pages: 560–570, Jean-Louis Delaunay, Alix Bruneau, Brice Hoffmann, Anne-Marie Durand-Schneider, Véronique Barbu, Emmanuel Jacquemin, Michèle Maurice, Chantal Housset, Isabelle Callebaut and Tounsia Aït-Slimane

    Version of Record online : 24 DEC 2016, DOI: 10.1002/hep.28929